These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11306921)
1. The role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of Th2 cell differentiation. Nakayama T; Yamashita M; Kawano T; Shimizu C; Shibata Y; Kamata T; Kaneko Y; Kobayashi S; Takeda U; Motohashi S; Cui J; Taniguchi M Int Arch Allergy Immunol; 2001; 124(1-3):38-42. PubMed ID: 11306921 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. Cui J; Watanabe N; Kawano T; Yamashita M; Kamata T; Shimizu C; Kimura M; Shimizu E; Koike J; Koseki H; Tanaka Y; Taniguchi M; Nakayama T J Exp Med; 1999 Sep; 190(6):783-92. PubMed ID: 10499917 [TBL] [Abstract][Full Text] [Related]
3. Role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of allergic diseases. Iwamura C; Nakayama T Allergol Int; 2007 Mar; 56(1):1-6. PubMed ID: 17259803 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617 [TBL] [Abstract][Full Text] [Related]
5. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104 [TBL] [Abstract][Full Text] [Related]
6. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033 [TBL] [Abstract][Full Text] [Related]
7. Essential role of LFA-1 in activating Th2-like responses by alpha-galactosylceramide-activated NKT cells. Matsumoto G; Kubota E; Omi Y; Lee U; Penninger JM J Immunol; 2004 Oct; 173(8):4976-84. PubMed ID: 15470040 [TBL] [Abstract][Full Text] [Related]
8. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Kawakami K; Kinjo Y; Yara S; Koguchi Y; Uezu K; Nakayama T; Taniguchi M; Saito A Infect Immun; 2001 Jan; 69(1):213-20. PubMed ID: 11119508 [TBL] [Abstract][Full Text] [Related]
9. IL-18 time-dependently modulates Th1/Th2 cytokine production by ligand-activated NKT cells. Uchida T; Kinoshita M; Fukasawa M; Habu Y; Shinomiya N; Seki S Eur J Immunol; 2007 Apr; 37(4):966-77. PubMed ID: 17330820 [TBL] [Abstract][Full Text] [Related]
10. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide. Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815 [TBL] [Abstract][Full Text] [Related]
11. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. Kitamura H; Iwakabe K; Yahata T; Nishimura S; Ohta A; Ohmi Y; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nishimura T J Exp Med; 1999 Apr; 189(7):1121-8. PubMed ID: 10190903 [TBL] [Abstract][Full Text] [Related]
12. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273 [TBL] [Abstract][Full Text] [Related]
13. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. Leite-De-Moraes MC; Hameg A; Pacilio M; Koezuka Y; Taniguchi M; Van Kaer L; Schneider E; Dy M; Herbelin A J Immunol; 2001 Jan; 166(2):945-51. PubMed ID: 11145671 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. Harada M; Seino K; Wakao H; Sakata S; Ishizuka Y; Ito T; Kojo S; Nakayama T; Taniguchi M Int Immunol; 2004 Feb; 16(2):241-7. PubMed ID: 14734609 [TBL] [Abstract][Full Text] [Related]
16. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Miyamoto K; Miyake S; Yamamura T Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362 [TBL] [Abstract][Full Text] [Related]
17. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Matsuda H; Suda T; Sato J; Nagata T; Koide Y; Chida K; Nakamura H Am J Respir Cell Mol Biol; 2005 Jul; 33(1):22-31. PubMed ID: 15802553 [TBL] [Abstract][Full Text] [Related]
18. Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-gamma and IL-4. Iizuka A; Ikarashi Y; Yoshida M; Heike Y; Takeda K; Quinn G; Wakasugi H; Kitagawa M; Takaue Y Immunology; 2008 Jan; 123(1):100-7. PubMed ID: 18005033 [TBL] [Abstract][Full Text] [Related]
19. Freshly isolated Valpha24+ CD4+ invariant natural killer T cells activated by alpha-galactosylceramide-pulsed B cells promote both IgG and IgE production. Rossignol A; Barra A; Herbelin A; Preud'homme JL; Gombert JM Clin Exp Immunol; 2007 Jun; 148(3):555-63. PubMed ID: 17362268 [TBL] [Abstract][Full Text] [Related]
20. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Taniguchi M; Harada M; Kojo S; Nakayama T; Wakao H Annu Rev Immunol; 2003; 21():483-513. PubMed ID: 12543936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]